BDBM50262971 (4-(naphthalen-2-yl)piperazin-1-yl)(2-p-tolyl-1-(3-(trifluoromethoxy)phenyl)-1H-imidazol-4-yl)methanone::CHEMBL504024

SMILES Cc1ccc(cc1)-c1nc(cn1-c1cccc(OC(F)(F)F)c1)C(=O)N1CCN(CC1)c1ccc2ccccc2c1

InChI Key InChIKey=NTKWSQGHJODGQP-UHFFFAOYSA-N

Data  1 IC50  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50262971   

TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262971((4-(naphthalen-2-yl)piperazin-1-yl)(2-p-tolyl-1-(3...)
Affinity DataIC50:  130nMAssay Description:Inhibition of human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(Homo sapiens (Human))
Merck Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50262971((4-(naphthalen-2-yl)piperazin-1-yl)(2-p-tolyl-1-(3...)
Affinity DataEC50:  3.15E+3nMAssay Description:Agonist activity against human CCK1 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed